Phase 1 Dose Escalation and Drug Distribution Study of Oral Terameprocol in Patients With Recurrent High Grade Glioma
Phase of Trial: Phase I
Latest Information Update: 20 Jun 2017
At a glance
- Drugs Terameprocol (Primary)
- Indications Glioma
- Focus Adverse reactions; Pharmacokinetics
- 08 Dec 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2021.
- 23 Dec 2015 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov record.
- 19 Oct 2015 New trial record